CDC5L
Cell division cycle 5-like protein
Also known as: CDC5, CDC5L_HUMAN, CEF1, hCDC5, PCDC5RP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99459
- Gene
- CDC5L
- Ensembl
- ENSG00000096401
- Chromosome
- 6
- Canonical length
- 802 aa
- Protein class
- Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene shares a significant similarity with Schizosaccharomyces pombe cdc5 gene product, which is a cell cycle regulator important for G2/M transition. This protein has been demonstrated to act as a positive regulator of cell cycle G2/M progression. It was also found to be an essential component of a non-snRNA spliceosome, which contains at least five additional protein factors and is required for the second catalytic step of pre-mRNA splicing. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
802 residues, UniProt reviewed canonical sequence.
>Q99459|CDC5L
1 MPRIMIKGGV WRNTEDEILK AAVMKYGKNQ WSRIASLLHR KSAKQCKARW YEWLDPSIKK
61 TEWSREEEEK LLHLAKLMPT QWRTIAPIIG RTAAQCLEHY EFLLDKAAQR DNEEETTDDP
121 RKLKPGEIDP NPETKPARPD PIDMDEDELE MLSEARARLA NTQGKKAKRK AREKQLEEAR
181 RLAALQKRRE LRAAGIEIQK KRKRKRGVDY NAEIPFEKKP ALGFYDTSEE NYQALDADFR
241 KLRQQDLDGE LRSEKEGRDR KKDKQHLKRK KESDLPSAIL QTSGVSEFTK KRSKLVLPAP
301 QISDAELQEV VKVGQASEIA RQTAEESGIT NSASSTLLSE YNVTNNSVAL RTPRTPASQD
361 RILQEAQNLM ALTNVDTPLK GGLNTPLHES DFSGVTPQRQ VVQTPNTVLS TPFRTPSNGA
421 EGLTPRSGTT PKPVINSTPG RTPLRDKLNI NPEDGMADYS DPSYVKQMER ESREHLRLGL
481 LGLPAPKNDF EIVLPENAEK ELEEREIDDT YIEDAADVDA RKQAIRDAER VKEMKRMHKA
541 VQKDLPRPSE VNETILRPLN VEPPLTDLQK SEELIKKEMI TMLHYDLLHH PYEPSGNKKG
601 KTVGFGTNNS EHITYLEHNP YEKFSKEELK KAQDVLVQEM EVVKQGMSHG ELSSEAYNQV
661 WEECYSQVLY LPGQSRYTRA NLASKKDRIE SLEKRLEINR GHMTTEAKRA AKMEKKMKIL
721 LGGYQSRAMG LMKQLNDLWD QIEQAHLELR TFEELKKHED SAIPRRLECL KEDVQRQQER
781 EKELQHRYAD LLLEKETLKS KFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDC5L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- tongue: 21 nTPM
- bone marrow: 20 nTPM
- parathyroid gland: 19 nTPM
- liver: 18 nTPM
- skeletal muscle: 17 nTPM
- thymus: 14 nTPM
Single-cell type
- late spermatids: 414 nCPM
- early spermatids: 381 nCPM
- megakaryocytes: 136 nCPM
- erythrocyte progenitors: 136 nCPM
- megakaryocyte progenitors: 127 nCPM
- megakaryocyte-erythroid progenitors: 119 nCPM
Immune cell
- basophil: 20 nTPM
- neutrophil: 20 nTPM
- non-classical monocyte: 18 nTPM
- eosinophil: 18 nTPM
- intermediate monocyte: 16 nTPM
- NK-cell: 15 nTPM
Brain region
- cerebellum: 21 nTPM
- white matter: 18 nTPM
- cerebral cortex: 17 nTPM
- hippocampal formation: 16 nTPM
- choroid plexus: 15 nTPM
- medulla oblongata: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDC5L.
Disease | ImmuneIEDB
Conditions an epitope on CDC5L was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.78
- DepMap mean gene effect
- -1.67
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA damage checkpoint signaling
- DNA repair
- mRNA splicing, via spliceosome
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- RNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- WD40-repeat domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SANT/Myb domain
- Homedomain-like superfamily
- Myb domain
- Myb-like DNA-binding domain
- Pre-mRNA splicing factor component Cdc5p/Cef1, C-terminal
- Pre-mRNA splicing factor component CDC5L/Cef1, second SANT/myb-like domain
- Pre-mRNA splicing factor component CDC5L/Cef1
- pre-mRNA splicing factor component
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDC5L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDC5L as an antibody target. Whether an autoantibody or antibody against CDC5L could matter depends on whether native CDC5L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDC5L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDC5L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...